UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004833 |
|---|---|
| Receipt number | R000005754 |
| Scientific Title | Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer |
| Date of disclosure of the study information | 2011/01/06 |
| Last modified on | 2022/01/14 12:55:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/01/06 20:05:00 | ||
| 2 | Update | 2011/01/07 14:46:18 | Key inclusion criteria |
|
| 3 | Update | 2011/08/07 15:18:47 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2011/11/07 14:33:48 | Institute Institute |
|
| 5 | Update | 2011/11/07 14:35:20 | Institute |
|
| 6 | Update | 2022/01/14 12:55:11 | Recruitment status Date of IRB Last follow-up date |
